The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21.1 - Manufacture of basic pharmaceutical products
438 jobs Number of planned job losses
Announcement Date
23 August 2012
Employment effect (start)
1 September 2012
Foreseen end date
1 October 2012
Description
Alapis, a Greek pharmaceutical company, dismissed 438 employees in Greece - both in the mother company and its subsidiaries. The company currently employs 1,400 people. The restructuring is attributed to a reduction in turnover, but a long-debated closure of the company has been averted.
The Alapis Group was created by the merger of Veterin SA, Lamda Detergent SA, EBIK SA and Elpharma SA. The Group is involved in the manufacturing and distribution of pharmaceuticals and para-pharmaceutical products, as well as powder detergents.
Sources
24 August 2012: Ta nea
24 August 2012: Imerisia
Citation
Eurofound (2012), Alapis, Internal restructuring in Greece, factsheet number 74201, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/74201.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
